Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study: British Journal of Haematology

for Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA), E. Lucchini, F. Palandri, S. Volpetti, N. Vianelli, G. Auteri, E. Rossi, A. Patriarca, G. Carli, W. Barcellini, M. Celli, U. Consoli, F. Valeri, C. Santoro, E. Crea, M. Vignetti, F. Paoloni, C.L. Gigliotti, E. Boggio, U. DianzaniI. Giardini, M. Carpenedo, F. Rodeghiero, R. Fanin, F. Zaja

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)386-396
Number of pages11
JournalBr. J. Haematol.
Volume193
Issue number2
DOIs
Publication statusPublished - 2021

Keywords

  • eltrombopag
  • ITP
  • SROT
  • sustained remission off-treatment
  • tapering

Cite this